RinGlar (insulin glargine biosimilar)
/ Geropharm
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 17, 2025
Comparative Study of Non-Inferiority Immunogenicity of GP40321 and Apidra ® SoloStar ® in Type 1 Diabetes Mellitus Patients
(clinicaltrials.gov)
- P3 | N=224 | Completed | Sponsor: Geropharm
New P3 trial • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus
1 to 1
Of
1
Go to page
1